Are these test results normal on a low-carb or ketogenic diet during the weight loss plateau phase?

Understanding Common Lab Shifts on Low-Carb and Ketogenic Diets

When patients hit a weight loss plateau on a low-carb or ketogenic diet, their labs often look different than standard reference ranges. This is expected. In the first 8–12 weeks of carbohydrate restriction, insulin drops sharply, prompting the liver to release stored fat and glycogen. This frequently elevates total cholesterol, LDL, and sometimes triglycerides while HDL climbs. These changes are usually transient and reflect metabolic adaptation rather than pathology.

During a plateau phase, which often occurs between weeks 10–16 in our protocol, many see a temporary rise in fasting glucose (95–110 mg/dL) even as fasting insulin falls below 8 µU/mL. This is the body recalibrating insulin resistance. Thyroid markers like TSH may increase slightly (up to 4.5 mIU/L) while free T3 dips because the body is conserving energy. These are normal adaptive responses, not reasons to panic or add medication. In "The 30-Week Tirzepatide Reset," we track these patterns across three 70-day cycles to confirm they resolve with continued lectin-free eating and smart cycling.

Key Labs to Watch and What “Normal” Really Means

Expect CRP to drop below 1.0 mg/L as lectin inflammation decreases. Liver enzymes ALT and AST often normalize even if they temporarily rise during fat mobilization. Electrolytes can shift: sodium may run low (135–138 mmol/L) while potassium stays stable when using our targeted Drops and adequate salt intake of 4–6 grams daily. Kidney function (BUN/creatinine) typically improves, but a mild creatinine bump from increased muscle preservation is common and benign.

In our clinic, we never adjust therapy based on a single snapshot. Instead, we compare trends every 10 weeks. A patient whose LDL jumps from 110 to 160 mg/dL but whose particle size improves (via NMR or ApoB under 90) is usually on the right track. The plateau itself often signals the hypothalamus resetting hunger signaling, not failure.

How the 30-Week Tirzepatide Reset Breaks Plateaus Safely

Our protocol uses low-dose tirzepatide cycling—never continuous high doses—to prevent metabolic slowdown. We pair one 2.5–5 mg box across 70 days with our exact 221-recipe lectin-free low-carb plan, Detox Drops, red light therapy, and Japanese-style walking intervals. This combination consistently lowers insulin resistance, reduces toxin burden, and restores leptin sensitivity so the scale moves again without chasing higher doses.

Focus on non-scale victories: reduced joint pain, better blood pressure (often dropping 10–15 systolic points), improved A1C (frequently 0.8–1.5 points in 10 weeks), and clothing size. John, a 52-year-old with diabetes and joint pain, saw his plateau at week 14 with elevated LDL. By continuing the protocol, adding chaotic intermittent fasting in maintenance, and using red light, he dropped 18 more pounds by week 30 and normalized every marker while staying off extra diabetes meds.

Practical Steps When Labs Look “Off” During Your Plateau

Retest in 4–6 weeks while staying consistent. Increase sodium and potassium through food and our Brown Detox Drops. Add 20-minute red light sessions 4x weekly to support thyroid and mitochondrial function. Walk 8,000 steps using 4-minute brisk intervals. If hormonal changes from perimenopause are a factor, the protocol’s emphasis on real-food detox addresses root causes insurance plans often ignore. Most patients see labs normalize and weight resume once the full system—food, cycling, movement, recovery—realigns metabolic freedom. The goal is never medication dependence but a body that naturally defends a healthy weight long after the last injection.